New York, NY: Springer New York, pp
TRIUMPH-1 (NCT05929066, n=2,339, 80 weeks, general obesity): 28.3% average weight loss on the 12mg dose
Tesamorelin, however, isnt a GLP-1 RA and currently isnt offered by many leading telehealth platforms such as Hims, Hers, Eden, Henry Meds, or Strut
DISCLAIMER: This product may be a complementary medicine and/or not have been evaluated and verified by the South African Health Products Regulatory Authority for its quality, safety or intended use
While it may indirectly aid fat loss by supporting recovery and digestive function, theres limited direct clinical evidence linking BPC-157 to significant fat reduction
Frequently Asked Questions Our Carmel clinic provides medically supervised weight loss and hormone therapy, including GLP-1 medications such as semaglutide and tirzepatide, HRT, TRT, metabolic testing, advanced lab work, and personalized nutrition coaching